Sabra Health Care REIT, Inc. (SBRA) stock
SBRANasdaqReal Estate Investment TrustsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 2, 2026Score 6/3059% above fair value
$20.25−0.10 (-0.49%)
Close on Nov 17, 2026Market cap $5.17BP/E 77.9Yield 5.93%
Sabra Health Care REIT price to sales ratio
The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.
Sabra Health Care REIT's price to sales ratio was 6.2× on Nov 11, 2026, against 6.5× a year earlier. Over the last 5 years it ranged from 4.2× to 6.8×, with a median of 5.8×.
Price to Sales Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 6.2× | −0.1 |
| 2025 | Dec 31, 2025 | 6.3× | +0.4 |
| 2024 | Dec 31, 2024 | 6.0× | +0.9 |
| 2023 | Dec 29, 2023 | 5.1× | +0.3 |
| 2022 | Dec 30, 2022 | 4.8× | −0.3 |
| 2021 | Dec 31, 2021 | 5.1× | −0.9 |
| 2020 | Dec 31, 2020 | 6.0× | −0.4 |
| 2019 | Dec 31, 2019 | 6.4× | +1.9 |
| 2018 | Dec 31, 2018 | 4.5× | −6.5 |
| 2017 | Dec 29, 2017 | 11.0× | +5.0 |
| 2016 | Dec 30, 2016 | 6.0× | +0.2 |
| 2015 | Dec 31, 2015 | 5.8× | −3.0 |
| 2014 | Dec 31, 2014 | 8.7× | +1.0 |
| 2013 | Dec 31, 2013 | 7.8× | −0.2 |
| 2012 | Dec 31, 2012 | 7.9× | – |
See a number that looks wrong?